{"id":387782,"date":"2020-11-24T09:43:54","date_gmt":"2020-11-24T14:43:54","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=387782"},"modified":"2020-11-24T09:43:54","modified_gmt":"2020-11-24T14:43:54","slug":"program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/","title":{"rendered":"Program for Oncopeptides virtual Capital Markets Day on November 30 is published"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">STOCKHOLM<\/span>, <span class=\"xn-chron\">Nov. 24, 2020<\/span> \/PRNewswire\/ &#8212; <b>Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), <\/b>a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announces that the company has finalized the program for the upcoming virtual capital markets day for investors, analysts and journalists on <span class=\"xn-chron\">November 30<\/span><sup>th<\/sup>, 2020. The program is available on the company&#8217;s website at: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2992234-1&amp;h=2102386146&amp;u=https%3A%2F%2Foncopeptides.se%2Fen%2Fcalendar%2F&amp;a=www.oncopeptides.com%2Fen%2Fcalendar%2F\" rel=\"nofollow noopener noreferrer\">www.oncopeptides.com\/en\/calendar\/<\/a><\/p>\n<p>The CMD will be webcasted live and accessible at: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2992234-1&amp;h=1555845147&amp;u=https%3A%2F%2Ftv.streamfabriken.com%2Foncopeptides-cmd-2020&amp;a=https%3A%2F%2Ftv.streamfabriken.com%2Foncopeptides-cmd-2020\" rel=\"nofollow noopener noreferrer\">https:\/\/tv.streamfabriken.com\/oncopeptides-cmd-2020<\/a><u>. <\/u><\/p>\n<p>The presentations from the capital markets day will be uploaded on the company website in conjunction with the meeting.<\/p>\n<p>\n        <b>Oncopeptides Virtual Capital Markets Day <\/b><br \/>\n        <br \/>14.00 &#8211; 16.00 CET (<span class=\"xn-chron\">8:00am-10am EST<\/span>) <span class=\"xn-chron\">November 30th, 2020<\/span><\/p>\n<p>\n        <b>&#8220;Building a Fully Integrated Biotechnology Company&#8221;<\/b>\n      <\/p>\n<p>\n        <b>Introduction and Strategy for Value Growth<\/b>\u00a0&#8211; Marty J Duvall, CEO Oncopeptides<\/p>\n<p>\n        <b>Multiple Myeloma<\/b>\n      <\/p>\n<p>\n        <b>&#8220;Myeloma remains one of the largest unmet medical needs within hematology&#8221;<\/b>\u00a0 <\/p>\n<ul type=\"disc\">\n<li>Assistant Professor <span class=\"xn-person\">Joshua Richter<\/span>, MD. Icahn School of Medicine at Mount Sinai Hospital, <span class=\"xn-location\">New York<\/span><\/li>\n<\/ul>\n<p>\n        <b>Relapsed refractory multiple myeloma and melflufen &#8211; clinical experience with melflufen<\/b>\n      <\/p>\n<p>\n        <b>Panel discussion <\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>Professor <span class=\"xn-person\">Paul Richardson<\/span>, MD, Dana-Farber Cancer Institute, <span class=\"xn-location\">Boston<\/span><\/li>\n<li>Associate Professor <span class=\"xn-person\">Maria-Victoria Mateos<\/span>, MD, PhD, University Hospital, Salamanca<\/li>\n<\/ul>\n<p>Moderated by <span class=\"xn-person\">Klaas Bakker<\/span>, MD, PhD, CMO Oncopeptides<\/p>\n<p>\n        <b>The clinical development program for melflufen<\/b>\n      <\/p>\n<p>\n        <b>&#8220;Understanding how melflufen can help patients the most&#8221; &#8211; <\/b><br \/>\n        <span class=\"xn-person\">Jakob Lindberg<\/span>, CSO Oncopeptides<\/p>\n<p>\n        <b>Successfully making the drug available for patients in the US<\/b>\n      <\/p>\n<p>\n        <b>Overview of US launch of melflufen<\/b>\u00a0&#8211; Marty J Duvall, CEO Oncopeptides<\/p>\n<p>\n        <b>Questions and Answers<\/b>\n      <\/p>\n<p>\n        <b>For more information, please contact:<\/b>\n      <\/p>\n<p>Rein Piir, Head of Investor Relations, Oncopeptides<br \/>E-mail: <a target=\"_blank\" href=\"mailto:rein.piir@oncopeptides.com\" rel=\"nofollow noopener noreferrer\">rein.piir@oncopeptides.com<\/a>\u00a0 <br \/>Cell phone: +46 70 853 72 92<\/p>\n<p>The information was submitted for publication at 15.30 CET on <span class=\"xn-chron\">November 24, 2020<\/span>.<\/p>\n<p>\n        <b>About Oncopeptides<\/b>\n      <\/p>\n<p>Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The lead product candidate melflufen, is a first in class peptide-drug conjugate that targets aminopeptidases and rapidly releases alkylating agents into tumor cells. Melflufen is in development as a new treatment for the hematological malignancy multiple myeloma and is being tested in multiple clinical studies including the pivotal phase 2 HORIZON study and the ongoing phase 3 OCEAN study.\u00a0Based on the results from the HORIZON study a New Drug Application has been submitted to the U.S. Food and Drug Administration, FDA, for accelerated approval of melflufen in combination with dexamethasone for treatment of adult patients with triple-class refractory multiple myeloma.\u00a0The FDA,\u00a0has\u00a0granted the\u00a0New Drug Application a priority review, with a PDUFA date of <span class=\"xn-chron\">February 28<\/span>, 2021.Oncopeptides&#8217; global Headquarters is in <span class=\"xn-location\">Stockholm, Sweden<\/span> and the U.S. Headquarters is situated in <span class=\"xn-location\">Boston, Mass.<\/span> The company is listed in the Mid Cap segment on Nasdaq Stockholm with the ticker ONCO. More information is available on\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2992234-1&amp;h=2150842819&amp;u=http%3A%2F%2Fwww.oncopeptides.com%2F&amp;a=www.oncopeptides.com\" rel=\"nofollow noopener noreferrer\">www.oncopeptides.com<\/a>.<\/p>\n<p>This information was brought to you by Cision <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2992234-1&amp;h=3935346563&amp;u=http%3A%2F%2Fnews.cision.com%2F&amp;a=http%3A%2F%2Fnews.cision.com\" rel=\"nofollow noopener noreferrer\">http:\/\/news.cision.com<\/a><\/p>\n<p>\n        <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2992234-1&amp;h=3524277632&amp;u=https%3A%2F%2Fnews.cision.com%2Foncopeptides-ab%2Fr%2Fprogram-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published%2Cc3242741&amp;a=https%3A%2F%2Fnews.cision.com%2Foncopeptides-ab%2Fr%2Fprogram-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published%2Cc3242741\" rel=\"nofollow noopener noreferrer\">https:\/\/news.cision.com\/oncopeptides-ab\/r\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published,c3242741<\/a>\n      <\/p>\n<p>The following files are available for download:<\/p>\n<div>\n<table cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prnsbt1 prnsbr1 prnsbb1 prnsbl1\">\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2992234-1&amp;h=2400085306&amp;u=https%3A%2F%2Fmb.cision.com%2FMain%2F15404%2F3242741%2F1339295.pdf&amp;a=https%3A%2F%2Fmb.cision.com%2FMain%2F15404%2F3242741%2F1339295.pdf\" class=\"prnews_a\" rel=\"nofollow noopener noreferrer\">https:\/\/mb.cision.com\/Main\/15404\/3242741\/1339295.pdf<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Press release &#8211; Program for Oncopeptides virtual Capital Markets Day<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO02524&amp;sd=2020-11-24\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published-301179789.html\">http:\/\/www.prnewswire.com\/news-releases\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published-301179789.html<\/a><\/p>\n<p>SOURCE  Oncopeptides AB<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=IO02524&amp;Transmission_Id=202011240940PR_NEWS_USPR_____IO02524&amp;DateId=20201124\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire STOCKHOLM, Nov. 24, 2020 \/PRNewswire\/ &#8212; Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announces that the company has finalized the program for the upcoming virtual capital markets day for investors, analysts and journalists on November 30th, 2020. The program is available on the company&#8217;s website at: www.oncopeptides.com\/en\/calendar\/ The CMD will be webcasted live and accessible at: https:\/\/tv.streamfabriken.com\/oncopeptides-cmd-2020. The presentations from the capital markets day will be uploaded on the company website in conjunction with the meeting. Oncopeptides Virtual Capital Markets Day 14.00 &#8211; 16.00 CET (8:00am-10am EST) November 30th, 2020 &#8220;Building a Fully Integrated Biotechnology Company&#8221; Introduction and Strategy for Value Growth\u00a0&#8211; Marty J &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Program for Oncopeptides virtual Capital Markets Day on November 30 is published&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-387782","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Program for Oncopeptides virtual Capital Markets Day on November 30 is published - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Program for Oncopeptides virtual Capital Markets Day on November 30 is published - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire STOCKHOLM, Nov. 24, 2020 \/PRNewswire\/ &#8212; Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announces that the company has finalized the program for the upcoming virtual capital markets day for investors, analysts and journalists on November 30th, 2020. The program is available on the company&#8217;s website at: www.oncopeptides.com\/en\/calendar\/ The CMD will be webcasted live and accessible at: https:\/\/tv.streamfabriken.com\/oncopeptides-cmd-2020. The presentations from the capital markets day will be uploaded on the company website in conjunction with the meeting. Oncopeptides Virtual Capital Markets Day 14.00 &#8211; 16.00 CET (8:00am-10am EST) November 30th, 2020 &#8220;Building a Fully Integrated Biotechnology Company&#8221; Introduction and Strategy for Value Growth\u00a0&#8211; Marty J &hellip; Continue reading &quot;Program for Oncopeptides virtual Capital Markets Day on November 30 is published&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-24T14:43:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO02524&amp;sd=2020-11-24\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Program for Oncopeptides virtual Capital Markets Day on November 30 is published\",\"datePublished\":\"2020-11-24T14:43:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\\\/\"},\"wordCount\":510,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO02524&amp;sd=2020-11-24\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\\\/\",\"name\":\"Program for Oncopeptides virtual Capital Markets Day on November 30 is published - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO02524&amp;sd=2020-11-24\",\"datePublished\":\"2020-11-24T14:43:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO02524&amp;sd=2020-11-24\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO02524&amp;sd=2020-11-24\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Program for Oncopeptides virtual Capital Markets Day on November 30 is published\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Program for Oncopeptides virtual Capital Markets Day on November 30 is published - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/","og_locale":"en_US","og_type":"article","og_title":"Program for Oncopeptides virtual Capital Markets Day on November 30 is published - Market Newsdesk","og_description":"PR Newswire STOCKHOLM, Nov. 24, 2020 \/PRNewswire\/ &#8212; Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announces that the company has finalized the program for the upcoming virtual capital markets day for investors, analysts and journalists on November 30th, 2020. The program is available on the company&#8217;s website at: www.oncopeptides.com\/en\/calendar\/ The CMD will be webcasted live and accessible at: https:\/\/tv.streamfabriken.com\/oncopeptides-cmd-2020. The presentations from the capital markets day will be uploaded on the company website in conjunction with the meeting. Oncopeptides Virtual Capital Markets Day 14.00 &#8211; 16.00 CET (8:00am-10am EST) November 30th, 2020 &#8220;Building a Fully Integrated Biotechnology Company&#8221; Introduction and Strategy for Value Growth\u00a0&#8211; Marty J &hellip; Continue reading \"Program for Oncopeptides virtual Capital Markets Day on November 30 is published\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-24T14:43:54+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO02524&amp;sd=2020-11-24","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Program for Oncopeptides virtual Capital Markets Day on November 30 is published","datePublished":"2020-11-24T14:43:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/"},"wordCount":510,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO02524&amp;sd=2020-11-24","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/","name":"Program for Oncopeptides virtual Capital Markets Day on November 30 is published - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO02524&amp;sd=2020-11-24","datePublished":"2020-11-24T14:43:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO02524&amp;sd=2020-11-24","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO02524&amp;sd=2020-11-24"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Program for Oncopeptides virtual Capital Markets Day on November 30 is published"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=387782"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387782\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=387782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=387782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=387782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}